News

Proactive Investors Australia – Proteomics International to present at diabetes conference featuring PromarkerD test

Proteomics International Laboratories Ltd (ASX:PIQ) has been invited to feature on the American Diabetes Association (ADA) TV News Network as a key opinion leader on diabetic kidney disease diagnostics during the ADA 79th Scientific Sessions conference in San Francisco. Proteomics managing director Richard Lipscombe said: “The PromarketD test can make a major difference for patients, healthcare providers and insurance companies because it could cut dramatically the number of people who are unaware, they have progressive kidney disease.

Article: Proteomics International to present at diabetes conference featuring PromarkerD test

Subscribe
  • This field is for validation purposes and should be left unchanged.